Complement Therapeutics

Complement Therapeutics is a clinical-stage biotechnology company advancing precision therapies for complement-mediated diseases, focusing initially on geographic atrophy, an advanced form of dry age-related macular degeneration

Biotech & Life Sciences

Sector

Seed

Stage

Biotechnology

Model

01Company Overview

02Backed By2 investors

BVBioGeneration Ventures→HVHadean Ventures→

Is this your company? Claim your profile

Startup Intelligence by F4F4 Research Engine

Companies with the same backers

1 company

TargED BiopharmaceuticalsBiotech & Life Sciences

BioGeneration Ventures, Hadean Ventures

Find the investors for your round→

04Recent Activity

FROM Hadean Ventures

Complement Therapeutics completed Cohort 2 dosing with a favourable IDMC recommendation to proceed to high-dose and expansion cohorts in the Phase I/II Opti-GAIN study.